Kinetik Holdings heads into the post-earnings session with a Q1 miss in hand, a major shareholder actively reducing its stake, and short sellers pulling back — a set of signals that point in distinctly different directions.
Q1 results filed after the close on May 6 landed below expectations on both lines. EPS came in at -$0.07, missing the $0.23 consensus estimate. Revenue of $410m fell short of the $439m forecast. The print arrives just as the stock had built some momentum — up 3.2% on the week and 8.1% over the past month, bringing the price to $50.45. Whether the miss disrupts that recovery is the question the market now faces heading into Thursday's earnings call.
The most striking development of the past two weeks is not in the short book — it's the insider register. ISQ Global Fund II, a principal shareholder, sold more than 1.04 million shares across eight separate transactions between April 22 and April 30, generating approximately $53m in proceeds at prices ranging from $48 to just over $50.50. That is a sustained and deliberate distribution at current levels. CEO Jamie Welch, who holds roughly 5.3% of shares outstanding, trimmed slightly in March but at a far smaller scale. The ISQ sales represent the dominant ownership story this week, and they arrived precisely as the stock was recovering from its early-April pullback — a pattern worth watching as the Q1 miss now tests how much demand absorbs that supply overhang.
Short positioning tells a contrasting story. Short interest has fallen sharply — down nearly 20% over the past month — to roughly 10% of the free float. That decline accelerated through April: from above 8.9 million shares in early April to 6.4 million by May 5, a period that coincides almost exactly with when ISQ began distributing shares. Borrow costs have collapsed in parallel. The cost to borrow peaked near 5.7% in early April and has since eased to 1.6%, a 64% decline over 30 days. Availability has loosened considerably alongside that. The short score, at 61.8, has retreated from its recent high of 69.8 on April 24, and availability in the lending market is far less constrained than it was a month ago. Taken together, this is not a setup where short pressure is building into earnings — it is one where it has materially unwound.
Options traders are more bullish than usual. The put/call ratio has dropped to 0.22, well below its 20-day average of 0.26, and nearly 1.4 standard deviations below that mean. That ranks among the most call-heavy readings of the past year, where the 52-week range runs from 0.056 to 0.68. The skew toward calls aligns with the stock's recent price strength, but it also means there is relatively little downside protection in place heading into what has now proved to be a soft print.
The Street had been leaning constructive into the result. Mizuho maintained its Outperform and raised its target to $51 on April 28. RBC Capital did the same at $50 on April 16. Wells Fargo upgraded KNTK to Overweight in late March with a $52 target. Truist initiated with a Buy and a $53 target. Against those, Barclays stays Equal-Weight at $46 and Jefferies holds at Hold. The consensus price target of just over $50 now sits approximately in line with the current price — meaning the Street's collective view is essentially that this stock is fairly valued, with the bull case hinging on Permian Basin gas production growth and free cash flow expansion, and the bear case centred on single-basin concentration risk and commodity price sensitivity. The EV/EBITDA multiple has eased modestly to around 9.9x over the past month, reflecting the recent price recovery rather than any re-rating.
How the market digests the Q1 miss — and whether the ISQ distribution continues — is the central question heading into the earnings call Thursday morning.
See the live data behind this article on ORTEX.
Open KNTK on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
